WELCOME TO The HEALTHCARE REPORT
Top Priorities for Health Leaders 2022-2023
August 4, 2022
There has never been a time in the history of the U.S. healthcare system in which the leaders of hospitals, medical groups, and health systems have faced a broader range of pressures of all kinds policy,
I'm For Real
Enter your details once to access all our information and resources
SpineGuard is a public company listed on the NYSE Alternext (ticker: ALSGD) in Paris since April 29, 2013. Pierre Jérôme and Stéphane Bette founded the company in January 2009 with the aim to fully exploit the great clinical and market potential of PediGuard, the first and only handheld device capable of alerting surgeons in real time to potential pedicular or vertebral breaches.
whitePaper | May 20, 2022
We, the G7 Health Ministers, met in Berlin, Germany, on 19 and 20 May 2022, at an extraordinary time of multiple, acute crises.
whitePaper | August 25, 2022
The revenue cycle process has a long and cumbersome history that continues to become more complex as policies, payer relationships, and patient expectations evolve.
whitePaper | February 15, 2022
Every provider wants to innovate to drive transformation that helps reduce variability, improve efficiency, and support optimal patient care. The question is, how disruptive, in a positive sense, is your innovation? Most innovations in provider organizations are, in truth, iterative tweaks. While tweaks are the cornerstone of continuous improvement lifecycles, iteration isn’t the kind of transformation needed in healthcare. Real innovation creates a disruptive solution that fundamentally changes how people and processes work together, for the better.
Healthcare organizations need to be prepared to transition to lease accounting standards (ASC 842, IFRS 16 or GASB 87), and ideally, have a plan for compliance before adoption dates kick in.
whitePaper | February 19, 2020
Technology investment is just part of revenue cycle management, and engaging patients in the financial side of their treatment will be a key theme at HIMSS20.
It contains patient engagement in their medical bills, pricing transparency when choosing treatments and medications ,organizational integration of revenue cycle management, automation of prior authorization
whitePaper | January 27, 2023
Big Pharma conducted most of its early-stage clinical studies in the West before incorporating Asian locations in later phase studies. Though the Asian region had limited experience in the beginning, over time, researchers’ and local regional experience.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE